medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2016, Número 5

<< Anterior Siguiente >>

Rev Invest Clin 2016; 68 (5)


Acute Respiratory Distress Syndrome Secondary to Influenza A(H1N1)pdm09: Clinical Characteristics and Mortality Predictors

Hernández-Cárdenas C, Serna-Secundino H, García-Olazarán JG, Aguilar-Pérez CL, Rocha-Machado J, Campos-Calderón LG, Lugo-Goytia G

Idioma: Ingles.
Referencias bibliográficas: 35
Paginas: 235-244
Archivo PDF: 135.30 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al. INER Working Group on Influenza. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;361:680-9.

  2. Domínguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically ill patients with 2009 influenza A (H1N1) in Mexico. JAMA. 2009;302:1880-7.

  3. Kumar A, Zarychanski R, Pinto R, et al.; Canadian Critical Care Trials Group H1N1 Collaborative. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA. 2009;302: 1872-9.

  4. Rello J, Rodríguez A, Ibañez P, et al. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care. 2009;13:R148.

  5. Borja-Aburto VH, Chowell G, Viboud C. Epidemiological characterization of a fourth wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: age shift and severity. Arch Med Res. 2012;43:563-70.

  6. Dávila-Torres J, Chowell G, Borja-Aburto VH, Viboud C, Grajalez- Muñiz C, Miller MA. Intense seasonal A/H1N1 influenza in Mexico, winter 2013-2014. Arch Med Res. 2015;46:63-70.

  7. E lnifro EM, Ashshi AM, Cooper RJ, Klapper PE. Multiplex PCR: Optimization and application in diagnostic virology. Clin Microb Rev. 2000;13:559-70.

  8. Vincent JL, Moreno R, Takala J, Willats S. The SOFA (Sepsisrelated Organ Failure Assessment) score to describe organ dysfunction/ failure. Intensive Care Med. 1996;22:707-10.

  9. A RDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526-33.

  10. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165:867-903.

  11. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.

  12. World Health Organization. WHO guidelines for pharmacologic management of pandemic (H1N1) 2009 influenza and other influenza viruses. Geneva (Switzerland): The Organization; 2009.

  13. Kleyweg RP, van der Meche FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve. 1991;14: 1103-9.

  14. Rodríguez A, Díaz E, Martín-Loeches I, et al. Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A. J Antimicrob Chemother. 2011;66: 1140-9.

  15. Muthuri SG, Venkatesan S, Myles PR, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med. 2014;2:395-404.

  16. Morens DM, Fauci AS. The 1918 influenza pandemic: insights for the 21st century. J Infect Dis. 2007;195:1018-28.

  17. Rice TW, Rubinson L, Uyeki TM, et al. Critical illness from 2009 pandemic Influenza A (H1N1) virus and bacterial co-infection in the United States. Crit Care Med. 2012;40:1487-98.

  18. Miller III RR, Markewitz BA, Rolfs RT, et al. Clinical findings and demographic factors associated with ICU admission in Utah due to novel 2009 influenza A(H1N1) infection. Chest. 2010;137:752-8.

  19. Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, Ramirez P. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care. 2009;13:R201.

  20. Hayden FC, Fritz RS, Lobo MC, Alvord W, Strober W, Straus SE. Local and systemic cytokine responses during experimental human Influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest. 1998;101:643-9.

  21. G ao R, Bhatnagar J, Blau DM. Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1). Role of the host immune response in pathogenesis. Am J Pathol. 2013;183:1258-68.

  22. Pfister R, Kochanek M, Leygeber T, et al. Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis. Crit Care. 2014;18:R44.

  23. World Health Organization. Obesity (body mass index >= 30) (age-standardized estimate) Data by country. Available at: http://apps.who.int/gho/data/node.main.A900A?lang=en

  24. Ribeiro AF, Pellini AC, Kitagawa BY, et al. Risk factors for death from influenza A (H1N1)pdm09, State of São Paulo, Brazil, 2009. PLoS One. 2015;10:e0118772.

  25. Fezeu L, Julia C, Henegar A. Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obes Rev. 2011;12:653-9.

  26. Díaz E, Rodríguez A, Martin-Loeches I, et al. Impact of obesity in patients infected with 2009 Influenza A(H1N1). Chest. 2011; 139:382-6.

  27. Smith RL, Ripps CS, Lewis ML. Elevated lactate dehydrogenase values in patients with Pneumocystis carinii pneumonia. Chest. 1998;93:967-92.

  28. T sui PT, Kwok ML, Yuen H, Lai ST. Severe acute respiratory syndrome: clinical outcomes and prognostic correlates. Emerg Infect Dis. 2003;9:1064-9.

  29. Choi KW, Chau TN, Tsang O, et al. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med. 2003;139:715-23.

  30. Crum-Cianflone NF. Bacterial, fungal, parasitic, and viral myositis. Clin Microbiol Rev. 2008;21:473-94.

  31. A yala E, Kagawa FT, Whener JH, Tam J. Rhabdomyolysis associated with 2009 influenza A (H1N1). JAMA. 2009;302:1863-4.

  32. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010;362:1708-19.

  33. Desdouits M, Munier S, Prevost MC, et al. Productive infection of human skeletal muscle cells by pandemic and seasonal influenza A(H1N1) viruses. PLoS One. 2013;8:e79628.

  34. Bagshaw SM, Sood MM, Long J, Fowler RA, Adhikari NKJ; Canadian Critical Care Trials Group H1N1 Collaborative. Acute kidney injury among critically ill patients with pandemic H1N1 influenza A in Canada: cohort study. BMC Nephrol. 2013;14:123.

  35. Martin-Loeches I, Papiol E, Rodríguez A, et al.; H1N1 SEMICYUC Working Group. Acute kidney injury in critical ill patients affected by influenza A (H1N1) virus infection. Crit Care. 2011; 15:R66.




2020     |     www.medigraphic.com